Abiomed News (NASDAQ:ABMD)
| Latest Abiomed News Headlines | | Date | Time | Source | | | 03/08/2006 | 9:00AM | PRNUS | ABIOMED to Showcase Advanced Circulatory Support Devices at American College of Cardiology's Annual Scientific Sessions
DANVERS, Mass. and ATLANTA, March 8 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD), a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart, today announced the showcase of its AB5000(TM) Circulatory Support System at the American... More...>> |
| 02/02/2006 | 8:45AM | PRNUS | ABIOMED Announces Third Quarter of Fiscal 2006 Financial Results
* Q3 2006 Revenue Growth of 10%
DANVERS, Mass., Feb. 2 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD) today released financial results for its third fiscal quarter of 2006 that ended on December 31, 2005. Revenue for the third quarter of fiscal 2006 grew 10% to $10.5 million compared to the same period of fiscal... More...>> |
| 01/26/2006 | 8:57AM | PRNUS | ABIOMED to Present at Brean Murray, Carret & Co. Small Cap Institutional Investor Conference
DANVERS, Mass., Jan. 26 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Brean Murray, Carret & Co. Small Cap Institutional Investor Conference on February 1, 2006 at 2:00 p.m. ET. The conference will... More...>> |
| 01/25/2006 | 8:30AM | PRNUS | ABIOMED Announces Conference Call and Webcast to Discuss Fiscal 2006 Third Quarter Financial Results
DANVERS, Mass., Jan. 25 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD) today announced that the Company will report financial results for the fiscal third quarter that ended on December 31, 2005 on Thursday, February 2, 2006 before the market opens. A conference call and webcast to discuss those results will... More...>> |
| 01/23/2006 | 3:42PM | PRNUS | ABIOMED to Showcase Suite of Advanced Circulatory Support Devices at Society of Thoracic Surgeons Conference
Exclusive FDA Labeling on Medical Devices for All Indications of Cardiac Recovery
DANVERS, Mass., and CHICAGO, Jan. 23 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD), a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart, today... More...>> |
| 01/16/2006 | 8:30AM | PRNUS | ABIOMED Appoints Ronald Dollens as Board Member
DANVERS, Mass., Jan. 16 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD), a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart, is pleased to announce that Ronald W. Dollens, retired President and Chief Executive Officer of Guidant... More...>> |
| 01/09/2006 | 9:07AM | PRNUS | ABIOMED Appoints Dorothy Puhy to Lead Director of Its Board
DANVERS, Mass., Jan. 9 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD), a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart, is pleased to announce that Dorothy E. Puhy, who has served as Director of ABIOMED and chair of its... More...>> |
| 11/02/2005 | 8:30AM | PRNUS | ABIOMED Announces Fiscal 2006 Second Quarter Financial Results
Highest Revenue Quarter and Most Patients on AB5000 Circulatory Support in ABIOMED History
DANVERS, Mass., Nov. 2 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD) today released financial results for the fiscal second quarter ended on September 30, 2005. As compared to the second quarter fiscal year 2005, revenue... More...>> |
| 10/17/2005 | 6:10PM | PRNUS | Data on ABIOMED's AB5000 Circulatory Support System Presented at TCT Shows Recovery Possible for Patients with AMI Cardiogenic S
Patients with Heart Attack Followed by Shock Provided with Timely Support Able to Recover and Avoid Heart Transplant
DANVERS, Mass., and WASHINGTON, Oct. 17 /PRNewswire-FirstCall/ -- 17th Annual Transcatheter Cardiovascular Therapeutics (TCT) Meeting, Booth #254 -- ABIOMED, Inc. (NASDAQ:ABMD), a leading developer, manufacturer... More...>> |
| 10/06/2005 | 12:07PM | PRNUS | ABIOMED Announces Schedule of Events at Upcoming TCT Conference
Eight ABIOMED Presentations and Live Impella Cases to be Presented at Leading Interventional Cardiology Meeting
DANVERS, Mass., Oct. 6 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD), a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing... More...>> |
| 09/30/2005 | 9:04AM | PRNUS | ABIOMED Appoints Louis Lataif to Board of Directors
DANVERS, Mass., Sept. 30 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD), a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart, announced today that Louis E. Lataif, Dean of the Boston University School of Management, has been... More...>> |
| 09/29/2005 | 4:51PM | PRNUS | LifeCell Expands Its Board of Directors
BRANCHBURG, N.J., Sept. 29 /PRNewswire-FirstCall/ -- LifeCell Corporation (NASDAQ:LIFC) announced today that it has expanded its Board of Directors and approved the appointment of Messrs. Michael R. Minogue and Robert P. Roche, Jr. to fill the newly created positions, effective as of October 1, 2005.
Mr. Minogue currently... More...>> |
| 09/20/2005 | 8:30AM | PRNUS | ABIOMED to Present at UBS Global Life Sciences Conference
DANVERS, Mass., Sept. 20 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference on September 29, 2005 at 12:00 p.m. ET. The conference will be held at the Grand Hyatt New... More...>> |
| 09/14/2005 | 8:30AM | PRNUS | ABIOMED to Present at ThinkEquity Partners 3rd Annual Growth Conference
DANVERS, Mass., Sept. 14 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the ThinkEquity Partners Annual Growth Conference on September 15, 2005 at 11:30 a.m. PDT. The conference will be held at the Ritz... More...>> |
| 09/07/2005 | 1:34PM | PRNUS | Cardiac and Vascular Surgery Associates Reports Multiple Successes Recovering Patients' Hearts With ABIOMED's AB5000 Support
Use of Groundbreaking Device and Early Intervention Helps Patients Recover without Enduring Heart Transplant
DANVERS, Mass., Sept. 7 /PRNewswire/ -- The Cardiac and Vascular Surgery Associates (CVSA) Group of St. Francis Hospital and The Indiana Heart Hospital, both in Indianapolis, announced success in supporting patients... More...>> |
| 08/02/2005 | 2:48PM | PRNUS | ABIOMED Announces Increased Reimbursement From CMS for Successful Recovery of the Native Heart
DANVERS, Mass., Aug. 2 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD) today announced that the Centers for Medicare and Medicaid Services (CMS) has increased reimbursement for external ventricular assist devices (VADs) with successful recovery of the native heart. This change impacts ABIOMED's AB5000 and BVS... More...>> |
| 07/28/2005 | 9:00AM | PRNUS | ABIOMED Announces Conference Call and Webcast to Discuss Fiscal 2006 First Quarter Financial Results
ABIOMED Announces Conference Call and Webcast to Discuss Fiscal
2006 First Quarter Financial Results
DANVERS, Mass., July 28 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD)
today announced that the Company will report financial results for the fiscal
first quarter that ended on June 30, 2005 on Thursday, August... More...>> |
| 07/25/2005 | 8:30AM | PRNUS | ABIOMED to Present at Adams Harkness' 25th Annual Summer Seminar
ABIOMED to Present at Adams Harkness' 25th Annual Summer Seminar
DANVERS, Mass., July 25 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD)
announced today that Michael R. Minogue, Chairman, President and Chief
Executive Officer, will present at the Adams Harkness' 25th Annual Summer
Seminar on August 2, 2005 at... More...>> |
| 06/23/2005 | 9:37PM | PRNUS | FDA Advisory Panel Voted ABIOMED's AbioCor(R) Submission Did Not Yet Meet HDE Standards; Additional Data is Requested
FDA Advisory Panel Voted ABIOMED's AbioCor(R) Submission Did Not
Yet Meet HDE Standards; Additional Data is Requested
Conference Call Scheduled for June 24, 2005 at 11:00 A.M. EASTERN
DANVERS, Mass., June 23 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD)
announced that after several rounds of voting, the Circulatory... More...>> |
| 05/31/2005 | 9:01AM | PRNUS | ABIOMED Announces Results for Fiscal Year Ended March 31, 2005
ABIOMED Announces Results for Fiscal Year Ended March 31, 2005
Total revenue growth of 48% over prior year, with record setting Q4 revenue of
$10.8M
DANVERS, Mass., May 31 /PRNewswire-FirstCall/ -- ABIOMED, Inc. (NASDAQ:ABMD)
today released financial results for its fiscal year ended March 31, 2005
("fiscal 2005") and... More...>> |
|
|
|